Myocardial Viability Testing in the Management of Ischemic Heart Failure.

Life (Basel) · 2022 · PMC9698475 · PMID 36362914

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, the follow-up of patients from the STICH trial after 20 years of enrollment showed a trend for better survival in the group of patients with viability, compared to the non-viable group, and once again assessing myocardial viability came into focus [ 26 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.